arformoterol
Selected indexed studies
- Update on Asthma Management Guidelines. (Mo Med, 2024) [PMID:39421468]
- Nebulized arformoterol: what is its place in the management of COPD? (Ther Adv Respir Dis, 2013) [PMID:23147985]
- The ICS/Formoterol Reliever Therapy Regimen in Asthma: A Review. (J Allergy Clin Immunol Pract, 2023) [PMID:36639054]
_Worker-drafted node — pending editorial review._
Connections
No connections recorded yet.
Sources
- The ICS/Formoterol Reliever Therapy Regimen in Asthma: A Review. (2023) pubmed
- Update on Asthma Management Guidelines. (2024) pubmed
- Nebulized arformoterol: what is its place in the management of COPD? (2013) pubmed
- Arformoterol tartrate in the treatment of COPD. (2010) pubmed
- Role of arformoterol in the management of COPD. (2008) pubmed
- Arformoterol: (R,R)-eformoterol, (R,R)-formoterol, arformoterol tartrate, eformoterol-sepracor, formoterol-sepracor, R,R-eformoterol, R,R-formoterol. (2004) pubmed
- Effect of Triple Therapy on Cardiovascular and Severe Cardiopulmonary Events in Chronic Obstructive Pulmonary Disease: A Post Hoc Analysis of a Randomized, Double-Blind, Phase 3 Clinical Trial (ETHOS). (2025) pubmed
- Review of drug safety and efficacy of arformoterol in chronic obstructive pulmonary disease. (2015) pubmed
- Predictors of Nebulized Arformoterol Treatment: A Retrospective Analysis of Medicare Beneficiaries with Chronic Obstructive Pulmonary Disease. (2019) pubmed
- Nebulized arformoterol in patients with COPD: a 12-week, multicenter, randomized, double-blind, double-dummy, placebo- and active-controlled trial. (2007) pubmed